![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmiweb.com/press-release/2024-05-24/curatis-holding-ag-publishes-annual-report-of-the-then-still-named-kinarus-group-for-fy2023-and-an
https://www.globenewswire.com/news-release/2023/07/12/2703225/0/en/Kinarus-Therapeutics-Announces-Personnel-Change.html
https://www.globenewswire.com/news-release/2023/06/02/2680939/0/en/Kinarus-Therapeutics-Publishes-Invitation-to-the-2023-Annual-General-Meeting.html
https://www.globenewswire.com/news-release/2023/05/11/2666251/0/en/Kinarus-Therapeutics-signed-CHF1-5-million-convertible-loan-agreement-with-ChaoDian-Hangzhou-Investment-Management.html
https://www.globenewswire.com/news-release/2023/04/28/2657075/0/en/Kinarus-Therapeutics-Holding-AG-Kinarus-receives-deadline-extension-from-SER-for-publication-of-its-2022-annual-financial-report.html
https://www.globenewswire.com/news-release/2023/02/21/2611708/0/en/Kinarus-Therapeutics-Phase-2-KINFAST-Covid-19-Clinical-Trial-Progress-Update.html
https://www.globenewswire.com/news-release/2023/01/17/2589544/0/en/Kinarus-Therapeutics-Reports-Preclinical-Data-in-Lung-Fibrosis-and-Discloses-Clinical-Development-Plan.html
https://www.globenewswire.com//news-release/2022/11/22/2560415/0/en/Kinarus-Receives-USPTO-Notice-of-Allowance-for-Lead-Therapeutic-Candidate-KIN001.html